Roles of gyrA Mutations in Resistance of Clinical Isolates and In Vitro Mutants of Bacteroides fragilis to the New Fluoroquinolone Trovafloxacin
We determined whether gyrA mutations were present in fluoroquinolone-resistant laboratory mutants derived from the Bacteroides fragilis reference strain ATCC 25285 and in clinical isolates of B. fragilis. The two first-step mutants selected on ciprofloxacin (CIP) were devoid of gyrA mutations, where...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
2000
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89971/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10858340/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.7.1842-1845.2000 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|